sulfadiazine has been researched along with AIDS-Related Opportunistic Infections in 68 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
AIDS-Related Opportunistic Infections: Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this international, noncomparative, randomized phase II trial, we evaluated the effectiveness and tolerance of atovaquone suspension (1500 mg orally twice daily) plus either pyrimethamine (75 mg per day after a 200-mg loading dose) or sulfadiazine (1500 mg 4 times daily) as treatment for acute disease (for 6 weeks) and as maintenance therapy (for 42 weeks) for toxoplasmic encephalitis (TE) in patients infected with human immunodeficiency virus." | 9.10 | Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche ( Andersen, J; Bosler, EM; Chirgwin, K; Hafner, R; Jayaweera, DT; Leport, C; Luft, BJ; McAuliffe, V; Morlat, P; Rajicic, N; Remington, J; Roque, C; Vilde, JL, 2002) |
| "An open, randomised, multicentre trial was conducted to evaluate the efficacy of thrice-weekly versus daily therapy with sulfadiazine-pyrimethamine in the prevention of relapses of toxoplasmic encephalitis in HIV-infected patients." | 9.09 | Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group. ( Arrizabalaga, J; Cosin, J; Cruceta, A; Domingo, P; Fariñas, MC; Ferrer, E; Gatell, JM; Gudiol, F; Knobel, H; Leyes, M; Martínez-Lacasa, J; Miró, JM; Podzamczer, D; Polo, R; Ramón, JM; Ribera, E; Sirera, G, 2000) |
| "The aim of the present pilot study was to compare the efficacy and safety of trimethoprim (TMP) and sulfamethoxazole (SMX) with those of the standard therapy pyrimethamine (P)-sulfadiazine (S) for the treatment of toxoplasmic encephalitis in patients with AIDS." | 9.08 | Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group. ( Angarano, G; Carosi, G; Casari, S; Chiodo, F; Donisi, A; Fiori, G; Gregis, G; Orani, A; Poggio, A; Ranieri, S; Speranza, F; Torre, D, 1998) |
| "This European multicenter study compares the efficacy and tolerance of the combination of pyrimethamine-clindamycin (Pyr-Cm) with the standard therapy pyrimethamine-sulfadiazine (Pyr-Sdz) for the treatment of toxoplasmic encephalitis (TE) in patients with AIDS." | 9.08 | Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. ( Clumeck, N; De Wit, S; Katlama, C; O'Doherty, E; Van Glabeke, M, 1996) |
| "Between February 1990 and June 1993, 105 patients with HIV infection were enrolled after each had had resolution of an acute episode of toxoplasmic encephalitis treated with sulfadiazine (1 g four times per day) plus pyrimethamine (50 mg/d) plus folinic acid (15 mg/d) for 4 to 8 weeks." | 9.08 | Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group. ( Bolao, F; Cosín, J; Domingo, P; Gatell, JM; Laguna, F; Miró, JM; Podzamczer, D; Santamaría, J; Sirera, G; Verdejo, J, 1995) |
| "A prospective study was conducted to evaluate azithromycin in combination with pyrimethamine for treatment of acute Toxoplasma encephalitis in patients with AIDS." | 9.07 | Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. ( Hazebroucq, V; Joly, V; Leport, C; Morlat, P; Raffi, F; Saba, J; Vildé, JL, 1993) |
| " The standard treatment for toxoplasmic encephalitis is pyrimethamine and sulfadiazine." | 7.71 | Treatment of Toxoplasma brain abscess with clindamycin and sulfadiazine in an AIDS patient with concurrent atypical Pneumocystis carinii pneumonia. ( Chen, ER; Chen, YS; Huang, CK; Lee, SS; Lin, HH; Lin, WR; Liu, YC; Tsai, HC, 2002) |
| "A patient with AIDS who was being treated with pyrimethamine and sulfadiazine for Toxoplasma encephalitis developed lumbar pain, dysuria, urinary frequency, and hematuria." | 7.69 | Sulfadiazine-induced multiple urolithiasis and acute renal failure in a patient with AIDS and Toxoplasma encephalitis. ( Collazos, J; Díaz, F; Martínez, E; Mayo, J, 1996) |
| " Provided prophylactic and therapeutic recommendations are complied with, outcome of this drug-related side effect is usually excellent, and rare relapses will similarly respond well." | 6.39 | Sulfadiazine-associated nephrotoxicity in patients with the acquired immunodeficiency syndrome. ( Becker, K; Häussinger, D; Jablonowski, H, 1996) |
| "In this international, noncomparative, randomized phase II trial, we evaluated the effectiveness and tolerance of atovaquone suspension (1500 mg orally twice daily) plus either pyrimethamine (75 mg per day after a 200-mg loading dose) or sulfadiazine (1500 mg 4 times daily) as treatment for acute disease (for 6 weeks) and as maintenance therapy (for 42 weeks) for toxoplasmic encephalitis (TE) in patients infected with human immunodeficiency virus." | 5.10 | Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche ( Andersen, J; Bosler, EM; Chirgwin, K; Hafner, R; Jayaweera, DT; Leport, C; Luft, BJ; McAuliffe, V; Morlat, P; Rajicic, N; Remington, J; Roque, C; Vilde, JL, 2002) |
| "An open, randomised, multicentre trial was conducted to evaluate the efficacy of thrice-weekly versus daily therapy with sulfadiazine-pyrimethamine in the prevention of relapses of toxoplasmic encephalitis in HIV-infected patients." | 5.09 | Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group. ( Arrizabalaga, J; Cosin, J; Cruceta, A; Domingo, P; Fariñas, MC; Ferrer, E; Gatell, JM; Gudiol, F; Knobel, H; Leyes, M; Martínez-Lacasa, J; Miró, JM; Podzamczer, D; Polo, R; Ramón, JM; Ribera, E; Sirera, G, 2000) |
| "Between February 1990 and June 1993, 105 patients with HIV infection were enrolled after each had had resolution of an acute episode of toxoplasmic encephalitis treated with sulfadiazine (1 g four times per day) plus pyrimethamine (50 mg/d) plus folinic acid (15 mg/d) for 4 to 8 weeks." | 5.08 | Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group. ( Bolao, F; Cosín, J; Domingo, P; Gatell, JM; Laguna, F; Miró, JM; Podzamczer, D; Santamaría, J; Sirera, G; Verdejo, J, 1995) |
| "This European multicenter study compares the efficacy and tolerance of the combination of pyrimethamine-clindamycin (Pyr-Cm) with the standard therapy pyrimethamine-sulfadiazine (Pyr-Sdz) for the treatment of toxoplasmic encephalitis (TE) in patients with AIDS." | 5.08 | Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. ( Clumeck, N; De Wit, S; Katlama, C; O'Doherty, E; Van Glabeke, M, 1996) |
| "The aim of the present pilot study was to compare the efficacy and safety of trimethoprim (TMP) and sulfamethoxazole (SMX) with those of the standard therapy pyrimethamine (P)-sulfadiazine (S) for the treatment of toxoplasmic encephalitis in patients with AIDS." | 5.08 | Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group. ( Angarano, G; Carosi, G; Casari, S; Chiodo, F; Donisi, A; Fiori, G; Gregis, G; Orani, A; Poggio, A; Ranieri, S; Speranza, F; Torre, D, 1998) |
| "A prospective study was conducted to evaluate azithromycin in combination with pyrimethamine for treatment of acute Toxoplasma encephalitis in patients with AIDS." | 5.07 | Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. ( Hazebroucq, V; Joly, V; Leport, C; Morlat, P; Raffi, F; Saba, J; Vildé, JL, 1993) |
| " The standard treatment for toxoplasmic encephalitis is pyrimethamine and sulfadiazine." | 3.71 | Treatment of Toxoplasma brain abscess with clindamycin and sulfadiazine in an AIDS patient with concurrent atypical Pneumocystis carinii pneumonia. ( Chen, ER; Chen, YS; Huang, CK; Lee, SS; Lin, HH; Lin, WR; Liu, YC; Tsai, HC, 2002) |
| "Sulfadiazine acute nephrotoxicity is reviving specially because of its use in toxoplasmosis in HIV-positive patients." | 3.70 | Patterns of sulfadiazine acute nephrotoxicity. ( Cano, T; Clemente, L; Crespo, M; Pascual, J; Quereda, C; Rivera, M, 2000) |
| "A patient with AIDS who was being treated with pyrimethamine and sulfadiazine for Toxoplasma encephalitis developed lumbar pain, dysuria, urinary frequency, and hematuria." | 3.69 | Sulfadiazine-induced multiple urolithiasis and acute renal failure in a patient with AIDS and Toxoplasma encephalitis. ( Collazos, J; Díaz, F; Martínez, E; Mayo, J, 1996) |
| "We report herein the case of an AIDS patient, treated with sulfadiazine because of Nocardia pneumonia, that came to the emergency room in acute renal failure." | 2.39 | Reversible acute renal failure due to sulfonamide-induced lithiasis in an AIDS patient. ( Chechile Toniolo, G; Fariña, LA; Palou Redorta, J, 1995) |
| "We report here two cases of nocardiosis in patients with HIV infection and review spanish literature up to 1993, with an analysis of the characteristics of this infection in our country." | 2.39 | [Nocardiosis in patients with human immunodeficiency virus infection in Spain]. ( Bacaicoa, A; Crespo, L; García-Onieva, E; Martín, C; Pascua, FJ; Sánchez Muñoz-Torrero, JF; Yñiguez, TR, 1995) |
| " Provided prophylactic and therapeutic recommendations are complied with, outcome of this drug-related side effect is usually excellent, and rare relapses will similarly respond well." | 2.39 | Sulfadiazine-associated nephrotoxicity in patients with the acquired immunodeficiency syndrome. ( Becker, K; Häussinger, D; Jablonowski, H, 1996) |
| "The current standard treatment for cerebral toxoplasmosis (pyrimethamine/sulfadiazine) often encounters problems of poor tolerability, adverse effects, frequent dropouts and non-availability of pyrimethamine/sulfadiazine in some parts of India." | 1.42 | Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting. ( Goswami, RP; Rahman, M; Ray, Y; Tripathi, SK, 2015) |
| "The retrieved renal calculi were negative for the common stones that are routinely tested for in our laboratory and had the macroscopic characteristics of a sulphadiazine stone." | 1.38 | Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosis. ( Hew, M; McGettigan, BD; McLean-Tooke, A; Phillips, E, 2012) |
| "Paracoccidioidomycosis is a systemic mycosis with a geographic distribution that is limited to Central and South America; Brazil has the highest number of cases." | 1.36 | Paracoccidioides brasiliensis causing a rib lesion in an adult AIDS patient. ( Dantas, KC; de Andrade, HF; de Freitas, RS; Garcia, RS; Magri, MM, 2010) |
| "Neurotoxoplasmosis was the most frequent presenting symptom of AIDS (53." | 1.30 | [Cerebral toxoplasmosis and AIDS in Martinique]. ( Bourée, P; Dumazedier, D; Magdeleine, C; Sobesky, G, 1997) |
| "Pneumocystis carinii prophylaxis in AIDS patients might be safety withdrawn after effective HAART." | 1.30 | [Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases]. ( de Górgolas Hernández, M; Fernández Guerrero, ML; García Delgado, R; García Vázquez, E, 1999) |
| "Ten (91%) of these 11 patients with recurrence showed focal persistent enhancement after the initial treatment of toxoplasmosis abscess." | 1.29 | Persistent enhancement after treatment for cerebral toxoplasmosis in patients with AIDS: predictive value for subsequent recurrence. ( Benmelha, Z; Bouvet, E; Casalino, E; Laissy, JP; Lariven, S; Parlier, C; Servois, V; Sibert, A; Soyer, P; Vachon, F, 1994) |
| "Sulfadiazine-nephropathy and -nephrolithiasis were well known complications of high dose sulfadiazine therapy 50 years ago." | 1.29 | [Sulfadiazine nephrolithiasis and nephropathy]. ( Furrer, H; Hess, B; Jaeger, P; von Overbeck, J, 1994) |
| "Cerebral toxoplasmosis is the most common opportunistic infection of the central nervous system in AIDS patients." | 1.29 | [Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone]. ( Cardenal, C; Gatell, JM; Guelar, A; Mallolas, J; Miró, JM; Soriano, E; Zamora, L, 1994) |
| "Three of 50 (6%) had hemichoreoathetosis." | 1.29 | Choreoathetosis in acquired immune deficiency syndrome patients with cerebral toxoplasmosis. ( Andreula, C; Angarano, G; Armenise, S; De Blasi, R; de Mari, M; Maggi, P; Romanelli, C; Zimatore, G, 1996) |
| "We described two patients with AIDS treated for cerebral toxoplasmosis who developed renal failure due to sulphadiazine-induced crystalluria." | 1.29 | Renal failure due to sulphadiazine in AIDS patients with cerebral toxoplasmosis. ( Echevarría, S; Fariñas, MC; González, A; González-Macías, J; Pérez del Molino, A; Sampedro, I, 1993) |
| "Sulphadiazine-induced crystalluria and acute renal failure is increasingly frequent." | 1.29 | Acute renal failure due to sulphadiazine crystalluria in AIDS patients. ( Abad, J; Albalate, M; Caramelo, C; Casado, S; de Sequera, P; Fernández Guerrero, M; Hernandez, J; Ortiz, A; Ramiro, E; Vazquez, A, 1996) |
| "One complication of this is acute renal failure secondary to sulphadiazine-induced crystalluria." | 1.29 | Renal ultrasonic findings in sulphadiazine-induced renal failure. ( Kane, D; Keating, S; Mulcahy, FM; Murphy, JM; Wilson, GF, 1996) |
| "A pregnant woman was diagnosed with central nervous system toxoplasmosis and human immunodeficiency virus infection." | 1.29 | Normal fetal outcome in a pregnancy with central nervous system toxoplasmosis and human immunodeficiency virus infection. A case report. ( Brown, GM; Hedriana, HL; Mitchell, JL; Williams, SB, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.47) | 18.7374 |
| 1990's | 49 (72.06) | 18.2507 |
| 2000's | 13 (19.12) | 29.6817 |
| 2010's | 4 (5.88) | 24.3611 |
| 2020's | 1 (1.47) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y | 1 |
| Zeng, YM | 1 |
| Lu, YQ | 1 |
| Qin, YY | 1 |
| Chen, YK | 1 |
| Goswami, RP | 2 |
| Rahman, M | 1 |
| Ray, Y | 1 |
| Tripathi, SK | 1 |
| de Freitas, RS | 1 |
| Dantas, KC | 1 |
| Garcia, RS | 1 |
| Magri, MM | 1 |
| de Andrade, HF | 1 |
| Diz, S | 1 |
| Barbolla, I | 1 |
| Egea, M | 1 |
| de Luna, G | 1 |
| McGettigan, BD | 1 |
| Hew, M | 1 |
| Phillips, E | 1 |
| McLean-Tooke, A | 1 |
| Ball, SC | 1 |
| Tsai, HC | 1 |
| Lee, SS | 1 |
| Lin, HH | 1 |
| Lin, WR | 1 |
| Chen, YS | 1 |
| Huang, CK | 1 |
| Liu, YC | 1 |
| Chen, ER | 1 |
| Lee, SA | 1 |
| James, CW | 1 |
| Szabo, S | 1 |
| Dressler, RM | 1 |
| Filice, G | 1 |
| Carnevale, G | 1 |
| Orsolini, P | 1 |
| Soldini, L | 1 |
| Meroni, V | 1 |
| Comolli, G | 1 |
| Carenzo, L | 1 |
| Lee, MW | 1 |
| Fong, KS | 1 |
| Hsu, LY | 1 |
| Lim, WK | 1 |
| Swaminathan, S | 1 |
| Pollett, S | 1 |
| Loblay, R | 1 |
| Macleod, C | 1 |
| de la Prada Alvarez, FJ | 1 |
| Prados Gallardo, AM | 1 |
| Tugores Vázquez, A | 1 |
| Uriol Rivera, M | 1 |
| Morey Molina, A | 1 |
| Arens, J | 1 |
| Barnes, K | 1 |
| Crowley, N | 1 |
| Maartens, G | 1 |
| Winstanley, P | 1 |
| Podzamczer, D | 2 |
| Miró, JM | 3 |
| Bolao, F | 1 |
| Gatell, JM | 3 |
| Cosín, J | 2 |
| Sirera, G | 2 |
| Domingo, P | 2 |
| Laguna, F | 1 |
| Santamaría, J | 1 |
| Verdejo, J | 1 |
| Kovacs, JA | 1 |
| Fariña, LA | 1 |
| Palou Redorta, J | 1 |
| Chechile Toniolo, G | 1 |
| Sánchez Muñoz-Torrero, JF | 1 |
| Yñiguez, TR | 1 |
| García-Onieva, E | 1 |
| Pascua, FJ | 1 |
| Crespo, L | 1 |
| Bacaicoa, A | 1 |
| Martín, C | 1 |
| Peh, CA | 1 |
| Kimber, TE | 1 |
| Shaw, DR | 1 |
| Clarkson, AR | 1 |
| Huber, W | 1 |
| Bautz, W | 1 |
| Classen, M | 1 |
| Schepp, W | 1 |
| Potter, JL | 1 |
| Kofron, WG | 1 |
| Laissy, JP | 1 |
| Soyer, P | 1 |
| Parlier, C | 1 |
| Lariven, S | 1 |
| Benmelha, Z | 1 |
| Servois, V | 1 |
| Casalino, E | 1 |
| Bouvet, E | 1 |
| Sibert, A | 1 |
| Vachon, F | 1 |
| Fernandez, JM | 1 |
| Sadaba, F | 1 |
| Villaverde, FJ | 1 |
| Alvaro, LC | 1 |
| Cortina, C | 1 |
| Marques, LP | 1 |
| Madeira, EP | 1 |
| Santos, OR | 1 |
| Furrer, H | 1 |
| von Overbeck, J | 1 |
| Jaeger, P | 1 |
| Hess, B | 1 |
| Rabaud, C | 1 |
| May, T | 1 |
| Amiel, C | 1 |
| Katlama, C | 3 |
| Leport, C | 4 |
| Ambroise-Thomas, P | 1 |
| Canton, P | 1 |
| Oksenhendler, E | 1 |
| Charreau, I | 1 |
| Tournerie, C | 1 |
| Azihary, M | 1 |
| Carbon, C | 1 |
| Aboulker, JP | 1 |
| Guelar, A | 1 |
| Mallolas, J | 1 |
| Zamora, L | 1 |
| Cardenal, C | 1 |
| Soriano, E | 1 |
| Walckenaer, G | 1 |
| Longuet, P | 1 |
| Perronne, C | 1 |
| Lacassin, F | 1 |
| Vildé, JL | 3 |
| Saba, J | 1 |
| Morlat, P | 3 |
| Raffi, F | 1 |
| Hazebroucq, V | 1 |
| Joly, V | 1 |
| Kronawitter, U | 1 |
| Jakob, K | 1 |
| Zoller, WG | 1 |
| Rauh, G | 1 |
| Goebel, FD | 1 |
| Mathelier-Fusade, P | 1 |
| Leynadier, F | 1 |
| McCabe, R | 1 |
| Chirurgi, V | 1 |
| Hedriana, HL | 1 |
| Mitchell, JL | 1 |
| Brown, GM | 1 |
| Williams, SB | 1 |
| Ajisawa, A | 1 |
| Ragnaud, JM | 1 |
| Dupon, M | 1 |
| Lacoste, D | 1 |
| Pellegrin, JL | 1 |
| Chene, G | 1 |
| Nath, A | 1 |
| Hobson, DE | 1 |
| Russell, A | 1 |
| Skolnick, AA | 1 |
| Fariñas, MC | 3 |
| Echevarría, S | 1 |
| Sampedro, I | 1 |
| González, A | 1 |
| Pérez del Molino, A | 1 |
| González-Macías, J | 2 |
| Asensi, V | 1 |
| Cartón, JA | 1 |
| Maradona, JA | 1 |
| de Oña, M | 1 |
| Melón, S | 1 |
| Martínez, A | 1 |
| Asensi, JM | 1 |
| Villar, H | 1 |
| Méndez, FJ | 1 |
| Arribas, JM | 1 |
| Murray-Pulsifer, K | 1 |
| Hein, R | 1 |
| Brunkhorst, R | 1 |
| Thon, WF | 1 |
| Schedel, I | 1 |
| Schmidt, RE | 1 |
| Caumes, E | 1 |
| Bocquet, H | 1 |
| Guermonprez, G | 1 |
| Rogeaux, O | 1 |
| Bricaire, F | 1 |
| Gentilini, M | 1 |
| Becker, K | 1 |
| Jablonowski, H | 1 |
| Häussinger, D | 1 |
| Rodríguez-Carballeira, M | 1 |
| Casagran, A | 1 |
| Moré, J | 1 |
| Argilaga, R | 1 |
| García, M | 1 |
| Díaz, F | 1 |
| Collazos, J | 1 |
| Mayo, J | 1 |
| Martínez, E | 1 |
| Maggi, P | 1 |
| de Mari, M | 1 |
| De Blasi, R | 1 |
| Armenise, S | 1 |
| Romanelli, C | 1 |
| Andreula, C | 1 |
| Zimatore, G | 1 |
| Angarano, G | 2 |
| De Wit, S | 1 |
| O'Doherty, E | 1 |
| Van Glabeke, M | 1 |
| Clumeck, N | 1 |
| Field, AS | 1 |
| Marriott, DJ | 1 |
| Milliken, ST | 1 |
| Brew, BJ | 1 |
| Canning, EU | 1 |
| Kench, JG | 1 |
| Darveniza, P | 1 |
| Harkness, JL | 1 |
| de Sequera, P | 1 |
| Albalate, M | 1 |
| Hernandez, J | 1 |
| Vazquez, A | 1 |
| Abad, J | 1 |
| Ramiro, E | 1 |
| Fernández Guerrero, M | 1 |
| Caramelo, C | 1 |
| Casado, S | 1 |
| Ortiz, A | 1 |
| Kane, D | 1 |
| Murphy, JM | 1 |
| Keating, S | 1 |
| Wilson, GF | 1 |
| Mulcahy, FM | 1 |
| de Luis, DA | 1 |
| Fortun, J | 1 |
| Pintado, V | 1 |
| Aller de la Fuente, R | 1 |
| Bourée, P | 1 |
| Dumazedier, D | 1 |
| Magdeleine, C | 1 |
| Sobesky, G | 1 |
| Campany, D | 1 |
| Sales, P | 1 |
| Grau, S | 1 |
| Saballs, P | 1 |
| Drobnic, L | 1 |
| Gimeno, JL | 1 |
| Torre, D | 1 |
| Casari, S | 1 |
| Speranza, F | 1 |
| Donisi, A | 1 |
| Gregis, G | 1 |
| Poggio, A | 1 |
| Ranieri, S | 1 |
| Orani, A | 1 |
| Chiodo, F | 1 |
| Fiori, G | 1 |
| Carosi, G | 1 |
| Arjol, AM | 1 |
| Sánchez, C | 1 |
| Dalmau, D | 1 |
| Montero, A | 1 |
| Cohen, JE | 1 |
| Martínez, DP | 1 |
| Giovannoni, AG | 1 |
| Dupont, B | 1 |
| García Vázquez, E | 1 |
| de Górgolas Hernández, M | 1 |
| García Delgado, R | 1 |
| Fernández Guerrero, ML | 1 |
| Colebunders, R | 1 |
| Depraetere, K | 1 |
| De Droogh, E | 1 |
| Kamper, A | 1 |
| Corthout, B | 1 |
| Bottiau, E | 1 |
| Ferrer, E | 1 |
| Ramón, JM | 1 |
| Ribera, E | 1 |
| Cruceta, A | 1 |
| Knobel, H | 1 |
| Polo, R | 1 |
| Leyes, M | 1 |
| Arrizabalaga, J | 2 |
| Martínez-Lacasa, J | 1 |
| Gudiol, F | 1 |
| Crespo, M | 1 |
| Quereda, C | 1 |
| Pascual, J | 1 |
| Rivera, M | 1 |
| Clemente, L | 1 |
| Cano, T | 1 |
| Fernández-Ayala, M | 1 |
| Nan, D | 1 |
| Asencio Marchante, R | 1 |
| Lissen Otero, E | 1 |
| Lightman, S | 1 |
| Lynn, WA | 1 |
| Chirgwin, K | 1 |
| Hafner, R | 1 |
| Remington, J | 1 |
| Andersen, J | 1 |
| Bosler, EM | 1 |
| Roque, C | 1 |
| Rajicic, N | 1 |
| McAuliffe, V | 1 |
| Jayaweera, DT | 1 |
| Luft, BJ | 1 |
| Iribarren, JA | 1 |
| Garde, C | 1 |
| Rodriguez-Arrondo, F | 1 |
| Blanco, A | 1 |
| Sasson, JP | 1 |
| Dratch, PL | 1 |
| Shortsleeve, MJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Dose-Escalation, Phase I/II Study of Oral Azithromycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS[NCT00000966] | Phase 1 | 45 participants | Interventional | Completed | |||
| Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis[NCT00000794] | Phase 2 | 100 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for sulfadiazine and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Reversible acute renal failure due to sulfonamide-induced lithiasis in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infection | 1995 |
[Nocardiosis in patients with human immunodeficiency virus infection in Spain].
Topics: Adult; AIDS-Related Opportunistic Infections; Fatal Outcome; HIV-1; Humans; Male; Microbial Sensitiv | 1995 |
[Acute kidney failure caused by sulfadiazine stones. A complication of the therapy of toxoplasmosis in AIDS].
Topics: Acute Kidney Injury; AIDS-Related Opportunistic Infections; Clindamycin; Drug Therapy, Combination; | 1993 |
[Intolerance to sulfonamides in HIV infected subjects. Toxic and allergic origin].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Drug Eruptions; Humans; P | 1993 |
Issues in toxoplasmosis.
Topics: AIDS-Related Opportunistic Infections; Animals; Clindamycin; Drug Therapy, Combination; Encephalitis | 1993 |
Movement disorders with cerebral toxoplasmosis and AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Basal Ganglia Diseases; Cerebral Cortex; Chorea; Drug | 1993 |
Sulfadiazine-associated nephrotoxicity in patients with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Age | 1996 |
[Empirical anti-toxoplasma therapy in cerebral AIDS and Chagas disease. Presentation of 2 cases, review of the literature and proposal of an algorithm].
Topics: Adult; AIDS-Related Opportunistic Infections; Algorithms; Antiprotozoal Agents; Brain Diseases; Chag | 1998 |
[Exotic pulmonary mycoses].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Bla | 1998 |
7 trials available for sulfadiazine and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-I | 2020 |
Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Drug Administration Schedule; Drug Therapy, Comb | 1995 |
Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Azithromycin; Drug Administration Sched | 1993 |
Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Clindamycin; Drug Therapy, Comb | 1996 |
Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Anti-Infective Agents; Encephalitis; Female; | 1998 |
Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Drug Therapy, Combination; Encep | 2000 |
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; AIDS-Related Opportunistic Infections; Ani | 2002 |
52 other studies available for sulfadiazine and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Clindamycin; Female; Huma | 2015 |
Paracoccidioides brasiliensis causing a rib lesion in an adult AIDS patient.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Bone Diseases, Infecti | 2010 |
[Disseminated cerebral haemorrhages in a patient with HIV infection].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral | 2011 |
Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosis.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Diagnosis, Differential; HIV-1; Humans; | 2012 |
A solitary brain lesion in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Drug Therapy, Combination; Femal | 2003 |
Treatment of Toxoplasma brain abscess with clindamycin and sulfadiazine in an AIDS patient with concurrent atypical Pneumocystis carinii pneumonia.
Topics: Adult; AIDS-Related Opportunistic Infections; Brain Abscess; Clindamycin; Drug Therapy, Combination; | 2002 |
Sulfadiazine-induced nephrolithiasis detected by spiral CT scan.
Topics: Adult; AIDS-Related Opportunistic Infections; Humans; Male; Sulfadiazine; Tomography, X-Ray Computed | 2004 |
Chemotherapy of toxoplasmic encephalitis in AIDS patients.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Encephalitis; Hum | 1989 |
Optic nerve toxoplasmosis and orbital inflammation as initial presentation of AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Blepharitis; CD4 Lymphocyte Count; Co | 2006 |
Sulfonamide crystals and acute renal failure.
Topics: Acute Kidney Injury; AIDS-Related Opportunistic Infections; Crystallization; HIV Infections; Humans; | 2006 |
[Acute renal failure due to sulfadiazine crystalluria].
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Alkalies; Animals; Antiprotozoal | 2007 |
Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiprotozoal Agents; Drug Ther | 2007 |
Drug treatment of toxoplasmic encephalitis in acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Atovaquone; Clindamycin; Coccidiostats; Humans; Naphthoquinon | 1995 |
Toxoplasmosis in AIDS: keeping the lid on.
Topics: AIDS-Related Opportunistic Infections; Drug Therapy, Combination; Encephalitis; Humans; Pyrimethamin | 1995 |
Acute renal failure due to sulphadiazine in a patient with acquired immunodeficiency syndrome (AIDS)
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infection | 1995 |
[Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS].
Topics: AIDS-Related Opportunistic Infections; Clindamycin; Dexamethasone; Drug Resistance, Microbial; Drug | 1995 |
Sulfadiazine/N4-acetylsulfadiazine crystalluria in a patient with the acquired immune deficiency syndrome (AIDS)
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Hemophilia A; Huma | 1994 |
Persistent enhancement after treatment for cerebral toxoplasmosis in patients with AIDS: predictive value for subsequent recurrence.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Atrophy; Brain; Brain Abscess; Drug Therapy, Com | 1994 |
Cataplexy associated with midbrain lesion.
Topics: Adult; AIDS-Related Opportunistic Infections; Cataplexy; HIV Seropositivity; Humans; Magnetic Resona | 1995 |
Renal alterations induced by sulfadiazine therapy in an AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Drug Therapy, Combination; Female; Humans; Kidney Calc | 1994 |
[Sulfadiazine nephrolithiasis and nephropathy].
Topics: Adult; AIDS-Related Opportunistic Infections; Bicarbonates; Fluid Therapy; HIV Infections; Humans; H | 1994 |
Extracerebral toxoplasmosis in patients infected with HIV. A French National Survey.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Animals; Clindamycin; Drug Therapy, Combination; | 1994 |
Toxoplasma gondii infection in advanced HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Encephalitis; Female; Humans; Male; Middle Ag | 1994 |
[Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone].
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Atovaquone; Clarithromycin; Clindamycin; Drug | 1994 |
[Recurrence of cerebral toxoplasmosis in 15 AIDS patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Brain; Clindamycin; Drug Therapy, Combination; Female; | 1994 |
Normal fetal outcome in a pregnancy with central nervous system toxoplasmosis and human immunodeficiency virus infection. A case report.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antibodies, Protozoan; Drug Hypersensitivity; | 1993 |
[Protozoan infections in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Administration, Inhalation; AIDS-Related Opportunistic Infection | 1993 |
[Cerebral toxoplasmosis in AIDS. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Cl | 1993 |
Obtaining drug for AIDS-related toxoplasmosis.
Topics: AIDS-Related Opportunistic Infections; Drugs, Investigational; Humans; Sulfadiazine; Toxoplasmosis | 1993 |
Renal failure due to sulphadiazine in AIDS patients with cerebral toxoplasmosis.
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Crystallization; Humans; Male; Su | 1993 |
[The clinical significance of culturing Toxoplasma gondii on blood and other organic media].
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Blood; Child; Culture Media; Drug Therapy, Co | 1993 |
Two central nervous system infectious diseases in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Hu | 1993 |
Symptomatic sulfadiazine crystalluria in AIDS patients: a report of two cases.
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Drug Therapy, Combination; Humans | 1993 |
Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasmic encephalitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Clindamy | 1995 |
[Acute renal insufficiency caused by a sulfadiazine in a patient with cerebral toxoplasmosis and AIDS].
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Humans; Ki | 1996 |
Sulfadiazine-induced multiple urolithiasis and acute renal failure in a patient with AIDS and Toxoplasma encephalitis.
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Crystalliz | 1996 |
Choreoathetosis in acquired immune deficiency syndrome patients with cerebral toxoplasmosis.
Topics: Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Athetosi | 1996 |
Myositis associated with a newly described microsporidian, Trachipleistophora hominis, in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Anti-Infective Agents; Drug Ther | 1996 |
Acute renal failure due to sulphadiazine crystalluria in AIDS patients.
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Crystalliz | 1996 |
Renal ultrasonic findings in sulphadiazine-induced renal failure.
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Crystallization; Humans; Male; Mi | 1996 |
[HIV infection and Lyell syndrome: a wake-up call concerning anti-inflammatory agents].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Inflammatory | 1997 |
[Cerebral toxoplasmosis and AIDS in Martinique].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Drug Therapy, Combination; Fema | 1997 |
[Desensitization with sulfadiazine in a patient with cerebral toxoplasmosis refractory to alternative treatment].
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Desensitization, Immunologic; Drug Eruptions; | 1998 |
[Acute encephalopathy caused by sulfadiazine and trimethoprim-sulfamethoxazole in a patient with AIDS].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Brain Neoplasms; | 1998 |
[Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; A | 1999 |
Obstructive nephropathy due to sulfa crystals in two HIV seropositive patients treated with sulfadiazine.
Topics: AIDS-Related Opportunistic Infections; Alkalies; Antiprotozoal Agents; Crystallization; Female; Flui | 1999 |
Patterns of sulfadiazine acute nephrotoxicity.
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Female; Hum | 2000 |
[Kidney failure caused by sulphadiazine in patients with toxoplasma encephalitis].
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Encephaliti | 2000 |
[Secondary prevention of opportunistic infections in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal A | 2001 |
Clinical microbiological case: visual problems in an HIV-positive patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Antiretroviral Therapy, | 2001 |
Empiric treatment of acute Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Encephalitis; Humans; Pyrimethamine; Sulfadiazine; Toxoplasmo | 1992 |
Renal US findings in sulfadiazine-induced crystalluria.
Topics: Adult; AIDS-Related Opportunistic Infections; Crystallization; Female; Humans; Kidney; Kidney Calcul | 1992 |